Home
Morrison & Foerster LLP
Mary Prendergast
Mary Prendergast
Morrison & Foerster LLP
ITC Exclusion Of DOWNSTREAM Products: What Remains Of EPROMS?
17 Oct 2022 | United States
Four Pitfalls To Avoid When Seeking To Terminate A Section 337 Investigation By Consent Order
17 Mar 2022 | United States
Public Interest At The ITC
17 Mar 2022 | United States
Downstream Remedy At The ITC: The Continuing Applicability Of The EPROMs Analysis
17 Mar 2022 | United States
#EachforEqual: Mary Prendergast
13 Mar 2020 | United States
Meet MoFo's Diverse IP Litigators: Mary Prendergast
01 Aug 2019 | United States
Beverage Brewing Capsules: Pre-Suit Knowledge Of Patent Not Required For Indirect Infringement
08 Jun 2016 | United States
No More Isolated DNA Patents, The Supreme Court Rules
01 Jul 2013 | United States
Australian Federal Court Upholds Myriad’s Gene Patent
04 Mar 2013 | Australia
Myriad Finally Gets Its Day In (The Supreme) Court
11 Dec 2012 | United States
Judges Don’t Budge In Myriad: Federal Circuit Again Finds Isolated Gene Sequences Are Patent-Eligible Subject Matter
20 Aug 2012 | United States
Uncertainty Prevails: Myriad Back To The Federal Circuit
03 Apr 2012 | United States
Federal Circuit Creates "Palpable" Confusion Surrounding Patent Eligibility
13 Sep 2011 | United States
Federal Circuit Decision In Myriad Genetics Confirms That Isolated Human DNA Molecules Are Patentable
11 Aug 2011 | United States
Surprise Reversal of U.S. Government Position Frames the Issues in Myriad Genetics’ Federal Circuit Appeal
09 Nov 2010 | United States
Contact Details
Washington, DC
Email Website
Washington, DC
United States

  © Mondaq® Ltd 1994 - 2024. All Rights Reserved.